Both ABCA1 inducer (A30) and cardiolipin peroxidase inhibitor (E3) were able to reduce cardiolipin oxidation in DKD podocytes, thus preventing progression of the disease.36 This evidence concerns the gene ABCA1 and diabetic kidney disease.